Clinical Trial Detail

NCT ID NCT04006301
Title First-in-Human Study of JNJ-74699157 in Participants With Tumors Harboring the KRAS G12C Mutation
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Janssen Research & Development, LLC
Indications

lung non-small cell carcinoma

Advanced Solid Tumor

Therapies

JNJ-74699157

Age Groups: adult senior

No variant requirements are available.